Edgewise Therapeutics, Inc. (EWTX) NASDAQ
37.07
+0.864(+2.39%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
37.07
+0.864(+2.39%)
Currency In USD
| Market Cap | 2.55B |
| Enterprise Value | 2.5B |
| P/E Ratio | -22.56 |
| PEG Ratio | 3.32 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 8.05 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -21.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.34 |
| Return On Equity | -0.33 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.27M |
| EBITDA | -165.53M |
| Net Income | -167.8M |
| Diluted EPS | -1.63 |
| Total Cash | 499.56M |
| Total Cash/Share | 4.66 |
| Total Debt | 3.79M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 22.61 |
| Book Value Per Share | 4.6 |
| 52-Week Change | 155.86 |
| 52-Week High | 40.77 |
| 52-Week Low | 12.15 |
| Moving Average 50 Days | 33.16 |
| Moving Average 200 Days | 24.86 |
| Average Volume | 1.14M |
| Shares Outstanding | 107.59M |
| % Held by Institutions | 115.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |